Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-13

FDA Approved: DORZOLAMIDE AND TIMOLOL — Original Application (Leading Pharma, LLC)

View source ↗

Summary

FDA approved Leading Pharma, LLC's dorzolamide hydrochloride and timolol maleate ophthalmic solution as an original application (ANDA 205295). The product lower…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide and Timolol Ophthalmic Solution (Dorzolamide hydrochloride and timolol maleate ophthalmic solution)

Snippet

ORIG AP for DORZOLAMIDE AND TIMOLOL (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION)